Shopping Cart
Remove All
Your shopping cart is currently empty
TRX585 is a humanized monoclonal antibody targeting immunoglobulin-like transcript 5 (ILT5). It possesses potent immunomodulatory activity, significantly activating human T cells and upregulating the expression of NKG2D and Fas ligand, thereby enhancing antitumor activity and exhibiting strong cytotoxicity. TRX585 is applicable for research on viral infections and malignant tumors.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | Inquiry | Inquiry | Inquiry | |
| 5 mg | Inquiry | Inquiry | Inquiry |
| Description | TRX585 is a humanized monoclonal antibody targeting immunoglobulin-like transcript 5 (ILT5). It possesses potent immunomodulatory activity, significantly activating human T cells and upregulating the expression of NKG2D and Fas ligand, thereby enhancing antitumor activity and exhibiting strong cytotoxicity. TRX585 is applicable for research on viral infections and malignant tumors. |
| Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.